18Apr 2021
Drug-related adverse effects of antivascular endothelial growth factor agents

Drug-related adverse effects of antivascular endothelial growth factor agents

Antivascular endothelial growth factor (VEGF) agents have provided historic therapeutic breakthroughs in the treatment of retinal disease. New anti-VEGF agents are emerging for the treatment of retinal vascular diseases. Both systemic and ocular adverse effect need to be understood in managing patients. This review aims to highlight the adverse effects seen with routine use of bevacizumab, ranibizumab and aflibercept...

  • #ophthalmology

Like

Save

Share